Free Guide to Understanding Pulmonary Embolism Risk

What Is a Pulmonary Embolism and Why It Matters

A pulmonary embolism (PE) occurs when a blood clot travels through the veins and becomes lodged in the lungs. This clot blocks blood flow to lung tissue, which can be life-threatening. According to the Centers for Disease Control and Prevention (CDC), between 60,000 and 100,000 Americans die from venous thromboembolism (which includes both deep vein thrombosis and pulmonary embolism) each year. Understanding PE is important because recognizing risk factors and warning signs may help you seek medical attention sooner.

The condition develops in stages. First, a clot forms, usually in a leg vein—a condition called deep vein thrombosis (DVT). The clot may break apart and travel through the bloodstream to the lungs. Once in the pulmonary arteries, the clot reduces blood oxygen levels. Your heart must work harder to pump blood around the blockage. In severe cases, PE can cause sudden death. The American Heart Association estimates that PE is responsible for approximately 15% of in-hospital deaths that could potentially be prevented.

PE symptoms vary depending on clot size and overall health. Some people experience chest pain, shortness of breath, rapid heartbeat, and coughing. Others may have mild symptoms that resemble a respiratory infection. Large clots can cause sudden severe symptoms including fainting, severe breathing difficulty, and shock. Smaller clots may produce no symptoms at all—a situation called subsegmental PE. This is why understanding your personal risk factors matters: it helps you recognize when symptoms warrant immediate medical evaluation.

The condition affects different age groups and populations. While PE can happen to anyone, certain life circumstances increase risk significantly. Young, healthy individuals may develop PE after surgery or during long flights. Older adults face higher risks due to age-related changes in blood clotting. Pregnant women and women taking birth control medications have elevated risk due to hormonal effects on clotting factors. Cancer patients undergoing chemotherapy face particularly high risks. Understanding these patterns helps people recognize their individual risk profile.

Practical Takeaway: PE is a serious but potentially preventable condition. Knowing the basic facts about how PE develops and who is most at risk creates a foundation for recognizing warning signs and understanding prevention strategies. If you experience sudden shortness of breath, chest pain, or rapid heartbeat—especially after surgery, travel, or periods of immobility—seek medical attention rather than waiting.

Common Risk Factors You Should Know About

Medical professionals organize PE risk factors into several categories. Understanding which factors apply to you allows you to take appropriate precautions. Immobility ranks among the most important risk factors. Prolonged bed rest after surgery, hospitalization, or illness slows blood circulation in the legs. This slower movement allows clots to form more easily. Airline flights exceeding four hours significantly increase PE risk because sitting for extended periods reduces leg blood flow. A study published in the British Medical Journal found that people on flights longer than eight hours had a roughly four-fold increased risk. Even desk jobs involving sitting for eight or more hours daily can contribute to clot formation.

Surgical procedures carry substantial PE risk. Orthopedic surgeries—particularly hip and knee replacements—top the list. During these operations, surgeons damage blood vessels, and the trauma triggers the body's clotting cascade. The American Academy of Orthopaedic Surgeons reports that without preventive measures, PE occurs in 40% to 50% of people undergoing hip or knee replacement. General abdominal surgery, cancer surgery, and gynecological procedures also carry elevated risks. The risk period extends beyond surgery itself; it can remain elevated for weeks or months during recovery as patients reduce movement.

Medical conditions that affect blood clotting create substantial PE risk. Cancer patients face particularly high risk—estimates suggest cancer-related PE occurs in up to 20% of hospitalized cancer patients. Certain cancers, particularly lung and pancreatic cancer, are more likely to cause clotting problems. Heart disease, particularly conditions causing heart rhythm irregularities (atrial fibrillation), increases risk. Chronic lung disease, obesity, and diabetes each affect blood vessel function and inflammation in ways that promote clotting. Previous blood clots or family history of clotting disorders indicates inherited or acquired clotting abnormalities. Chronic kidney disease interferes with natural anticoagulation mechanisms. Infections causing sepsis can trigger excessive clotting.

Hormonal and lifestyle factors substantially influence PE risk. Oral contraceptives (birth control pills) increase risk by three to four times compared to women not using them. Hormone replacement therapy (HRT) used for menopausal symptoms similarly elevates risk. Pregnancy itself increases risk five to six times, and this elevated risk continues for six weeks after delivery. Smoking damages blood vessel walls and increases clotting tendency. Obesity puts pressure on leg veins, impeding blood flow and causing inflammation that promotes clotting. Dehydration reduces blood volume, concentrating clotting factors and increasing clot risk. Recent air travel, car travel, or immobility combines with these factors to raise overall risk significantly.

Genetic predispositions play an important role in PE risk. Factor V Leiden mutation, present in about 5% of people of European descent, disrupts normal anticoagulation mechanisms. Prothrombin gene mutation (Factor II mutation) similarly increases clotting risk. Antithrombin III deficiency, protein C deficiency, and protein S deficiency all represent inherited conditions affecting the body's natural anticoagulation systems. About 5% to 10% of PE cases involve inherited thrombophilia (clotting tendency). If multiple family members have experienced blood clots before age 50, or if you have a family member with identified genetic clotting disorders, genetic testing may be worth discussing with your physician.

Practical Takeaway: Review the risk factors in each category and identify which ones apply to your situation. Create a personal risk profile noting whether you have immobility risk (upcoming surgery, planned travel), medical conditions that increase clotting tendency, hormonal factors, or lifestyle contributors. Share this profile with your healthcare provider—especially before planned surgeries or travel. Even recognizing two or three risk factors together warrants a conversation about prevention measures.

How Age, Gender, and Medical History Shape Your Risk

Age significantly influences PE risk, though clots can develop at any age. The CDC reports that PE rates increase substantially with age. While younger people average approximately 0.5 PE cases per 1,000 person-years, those over 65 experience rates closer to 2 to 3 per 1,000 person-years. This nearly five-fold increase reflects both accumulated wear on blood vessels and higher rates of medical conditions predisposing to clotting. Adults over 80 face some of the highest PE risks. However, age alone does not determine risk—younger people with multiple other risk factors can develop PE at the same rates as older individuals with fewer risk factors.

The reason age increases PE risk involves multiple biological changes. Blood vessel walls become stiffer and less flexible with age, disrupting normal blood flow patterns. Platelets (clotting cells) become more reactive in older adults, responding more readily to triggers for clot formation. Kidney function typically declines with age, reducing elimination of clotting factors. Immune system changes alter the inflammatory response, which influences clotting tendency. Older adults more frequently have conditions like atrial fibrillation, cancer, or heart disease that independently increase PE risk. Surgery or hospitalization affects older adults more severely due to reduced mobility recovery and increased deconditioning. These cumulative factors explain why age represents such a substantial risk multiplier.

Gender differences in PE risk deserve specific attention. Women aged 15 to 44 have higher PE rates than men the same age, primarily due to oral contraceptive use and pregnancy. The American College of Obstetricians and Gynecologists reports that pregnancy increases PE risk five to six times compared to non-pregnant women. The risk remains elevated for six weeks after delivery and extends to 12 weeks post-pregnancy if complications develop. Cesarean delivery increases PE risk further compared to vaginal delivery. After age 50, gender differences narrow, and men and women have similar baseline PE rates. However, women using hormone replacement therapy during menopause maintain elevated risk, while post-menopausal women not using hormones return to baseline risk similar to men.

Personal medical history substantially shapes current PE risk. People who have experienced one blood clot face roughly a 25% to 30% risk of experiencing a second clot within 10 years if they